SAU YEE: Open Payments
NPI 1740288570 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 30 payments from 14 companies in 2025. Trend: 2023 $1,128 · 2024 $1,067 · 2025 $807
Food & beverage: $791Education: $16
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $275 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $93 |
| PFIZER INC. | 4 | $64 |
| Novo Nordisk Inc | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Lundbeck LLC | 2 | $35 |
| Exact Sciences Corporation | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: REPATHA, AIRSUPRA, OTEZLA, JARDIANCE, Kerendia, VYEPTI, Ozempic, NURTEC ODT.
Industry payments across NJ — which companies pay providers there.
